We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Provider of VNAs for Oncology Sites Reaches Significant Milestone

By MedImaging International staff writers
Posted on 26 Sep 2016
Print article
Image: The Synapse VNA is provides medical image and information management for enterprises (Photo courtesy of FUJIFILM).
Image: The Synapse VNA is provides medical image and information management for enterprises (Photo courtesy of FUJIFILM).
A large diagnostic imaging products and medical informatics solutions provider has announced that they have reached a milestone in the number of installations of their enterprise-wide medical information and image management Vendor Neutral Archive (VNA).

The company has installed more than 300 of the scalable VNA storage systems, used for managing cancer treatment data, at oncology sites around the world. The VNA manages all DICOM (Digital Imaging and Communications in Medicine) and non-DICOM clinical oncology department data, used in the treatment of cancer patients. The data includes radiology diagnostic images, radiation treatment plans, and other clinical data. The oncology facilities that use the Synapse VNA interface more than 800 linear accelerators (linacs).

FUJIFILM Medical Systems U.S.A. (Stamford, CT, USA) developed the Synapse VNA technology interface. The company is also a leading worldwide provider of diagnostic imaging products, and medical informatics solutions, including digital X-Ray systems, Radiology Information Systems (RIS), the Synapse PACS (Picture Archiving and Communication System), cardiovascular products, and advanced imaging systems for the women’s health market. The Synapse VNA enables clinicians to access and securely share the data and back it up, with disaster recovery capabilities.

VP of FUJIFILM Medical Systems TeraMedica Division USA, Greg Strowig, said, “Fujifilm truly dominates the oncology VNA space both for our innovative technology and also our knowledge of what it takes to deliver better cancer care. Cancer centers across the globe have turned to us because of our unparalleled experience with the management of cancer treatment data.”

Related Links:
FUJIFILM Medical Systems U.S.A.

Silver Member
X-Ray QA Meter
T3 AD Pro
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Wall Fixtures
MRI SERIES
Digital X-Ray Detector Panel
Acuity G4

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.